{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T03:38:53Z","timestamp":1773027533849,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1007\/s11920-006-0049-4","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T08:48:06Z","timestamp":1180774086000},"page":"445-451","source":"Crossref","is-referenced-by-count":9,"title":["Vagus nerve stimulation (VNS) for depression: What do we know now and what should be done next?"],"prefix":"10.1007","volume":"8","author":[{"given":"Ziad","family":"Nahas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milton J.","family":"Foust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baron","family":"Short","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tal","family":"Herbsman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl 20","key":"49_CR1","first-page":"5","volume":"59","author":"RM Hirschfeld","year":"1998","unstructured":"Hirschfeld RM: American health care systems and depression: the past, present, and the future. J Clin Psychiatry 1998, 59(Suppl 20):5\u201310.","journal-title":"J Clin Psychiatry"},{"key":"49_CR2","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994."},{"key":"49_CR3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0006-3223(02)01405-1","volume":"52","author":"EJ Nestler","year":"2002","unstructured":"Nestler EJ, Gould E, Manji H, et al.: Preclinical models: status of basic research in depression. Biol Psychiatry 2002, 52:503\u2013528.","journal-title":"Biol Psychiatry"},{"key":"49_CR4","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0006-3223(03)00188-4","volume":"53","author":"DJ Kupfer","year":"2003","unstructured":"Kupfer DJ, Charney DS: Difficult-to-treat depression. Biol Psychiatry 2003, 53:633\u2013634.","journal-title":"Biol Psychiatry"},{"key":"49_CR5","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1176\/ajp.2006.163.9.1519","volume":"163","author":"AA Nierenberg","year":"2006","unstructured":"Nierenberg AA, Fava M, Trivedi MH, et al.: A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report. Am J Psychiatry 2006, 163:1519\u20131530; quiz 1665.","journal-title":"Am J Psychiatry"},{"key":"49_CR6","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1176\/ajp.2006.163.9.1531","volume":"163","author":"PJ McGrath","year":"2006","unstructured":"McGrath PJ, Stewart JW, Fava M, et al.: Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. Am J Psychiatry 2006, 163:1531\u20131541; quiz 1666.","journal-title":"Am J Psychiatry"},{"key":"49_CR7","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1176\/ajp.2006.163.7.1161","volume":"163","author":"M Fava","year":"2006","unstructured":"Fava M, Rush AJ, Wisniewski SR, et al.: A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. Am J Psychiatry 2006, 163:1161\u20131172.","journal-title":"Am J Psychiatry"},{"key":"49_CR8","first-page":"51","volume":"51","author":"ME Thase","year":"1990","unstructured":"Thase ME: Relapse and recurrence in unipolar major depression: short-term and long-term approaches. J Clin Psychiatry 1990, 51(Suppl):51\u201357.","journal-title":"J Clin Psychiatry"},{"key":"49_CR9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0006-3223(02)01467-1","volume":"52","author":"E Frank","year":"2002","unstructured":"Frank E, Rush AJ, Blehar M, et al.: Skating to where the puck is going to be: a plan for clinical trials and translation research in mood disorders. Biol Psychiatry 2002, 52:631\u2013654.","journal-title":"Biol Psychiatry"},{"key":"49_CR10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archpsyc.1990.01810240013002","volume":"47","author":"E Frank","year":"1990","unstructured":"Frank E, Kupfer DJ, Perel JM, et al.: Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990, 47:1093\u20131099.","journal-title":"Arch Gen Psychiatry"},{"key":"49_CR11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1042-3680(18)30485-6","volume":"6","author":"GR Cosgrove","year":"1995","unstructured":"Cosgrove GR, Rauch SL: Psychosurgery. Neurosurg Clin N Am 1995, 6:167\u2013176.","journal-title":"Neurosurg Clin N Am"},{"key":"49_CR12","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0006-3223(98)00110-3","volume":"44","author":"MB Keller","year":"1998","unstructured":"Keller MB, Boland RJ: Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatry 1998, 44:348\u2013360.","journal-title":"Biol Psychiatry"},{"key":"49_CR13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1176\/ajp.139.4.471","volume":"139","author":"AF Schatzberg","year":"1982","unstructured":"Schatzberg AF, Orsulak PJ, Rosenbaum AH, et al.: Toward a biochemical classification of depressive disorders, V: heterogeneity of unipolar depressions. Am J Psychiatry 1982, 139:471\u2013475.","journal-title":"Am J Psychiatry"},{"issue":"Suppl 2","key":"49_CR14","doi-asserted-by":"crossref","first-page":"91S","DOI":"10.1016\/S0893-133X(99)00036-6","volume":"21","author":"P Blier","year":"1999","unstructured":"Blier P, de Montigny C: Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 1999, 21(Suppl 2):91S-98S.","journal-title":"Neuropsychopharmacology"},{"key":"49_CR15","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/nn943","volume":"5","author":"CB Nemeroff","year":"2002","unstructured":"Nemeroff CB, Owens MJ: Treatment of mood disorders. Nat Neurosci 2002, 5(Suppl):1068\u20131070.","journal-title":"Nat Neurosci"},{"key":"49_CR16","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1124\/jpet.102.042788","volume":"304","author":"DA Gutman","year":"2003","unstructured":"Gutman DA, Owens MJ, Skelton KH, et al.: The corticotropin-releasing factor1 receptor antagonist R121919 attenuates the behavioral and endocrine responses to stress. J Pharmacol Exp Ther 2003, 304:874\u2013880.","journal-title":"J Pharmacol Exp Ther"},{"key":"49_CR17","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archpsyc.56.11.1043","volume":"56","author":"G Sanacora","year":"1999","unstructured":"Sanacora G, Mason GF, Rothman DL, et al.: Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1999, 56:1043\u20131047.","journal-title":"Arch Gen Psychiatry"},{"key":"49_CR18","first-page":"95","volume":"269","author":"IA Paul","year":"1994","unstructured":"Paul IA, Nowak G, Layer RT, et al.: Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. J Pharmacol Exp Ther 1994, 269:95\u2013102.","journal-title":"J Pharmacol Exp Ther"},{"key":"49_CR19","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1523\/JNEUROSCI.22-08-03251.2002","volume":"22","author":"Y Shirayama","year":"2002","unstructured":"Shirayama Y, Chen AC, Nakagawa S, et al.: Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 2002, 22:3251\u20133261.","journal-title":"J Neurosci"},{"key":"49_CR20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0920-1211(00)00181-9","volume":"42","author":"G Elger","year":"2000","unstructured":"Elger G, Hoppe C, Falkai P, et al.: Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 2000, 42:203\u2013210.","journal-title":"Epilepsy Res"},{"key":"49_CR21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/ebeh.2000.0046","volume":"1","author":"CL Harden","year":"2000","unstructured":"Harden CL, Pulver MC, Ravdin LD, et al.: A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 2000, 1:93\u201399.","journal-title":"Epilepsy Behav"},{"key":"49_CR22","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0193-953X(05)70196-9","volume":"23","author":"MS George","year":"2000","unstructured":"George MS, Sackeim HA, Marangell LB, et al.: Vagus nerve stimulation. A potential therapy for resistant depression? Psychiatr Clin North Am 2000, 23:757\u2013783.","journal-title":"Psychiatr Clin North Am"},{"key":"49_CR23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2007-1014476","volume":"23","author":"RM Post","year":"1990","unstructured":"Post RM: Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anticonvulsant carbamazepine. Pharmacopsychiatry 1990, 23:3\u201317.","journal-title":"Pharmacopsychiatry"},{"key":"49_CR24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1528-1157.1998.tb01448.x","volume":"39","author":"TR Henry","year":"1998","unstructured":"Henry TR, Bakay RA, Votaw JR, et al.: Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation. Epilepsia 1998, 39:983\u2013990.","journal-title":"Epilepsia"},{"key":"49_CR25","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1528-1157.1998.tb01155.x","volume":"39","author":"SE Krahl","year":"1998","unstructured":"Krahl SE, Clark KB, Smith DC, Browning RA: Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 1998, 39:709\u2013714.","journal-title":"Epilepsia"},{"key":"49_CR26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/cne.900670104","volume":"67","author":"JO Foley","year":"1937","unstructured":"Foley JO, DuBois F: Quantitative studies of the vagus nerve in the cat. I. The ratio of sensory and motor studies. J Comp Neurol 1937, 67:49\u201367.","journal-title":"J Comp Neurol"},{"key":"49_CR27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-8993(77)90275-X","volume":"130","author":"RA Hallowitz","year":"1977","unstructured":"Hallowitz RA, MacLean PD: Effects of vagal volleys on units of intralaminar and juxtalaminar thalamic nuclei in monkeys. Brain Res 1977, 130:271\u2013286.","journal-title":"Brain Res"},{"key":"49_CR28","volume-title":"The Triune Brain in Evolution: Role in Paleocerebral Functions","author":"PD MacLean","year":"1990","unstructured":"MacLean PD: The Triune Brain in Evolution: Role in Paleocerebral Functions. New York: Plenum Press; 1990."},{"issue":"6 Suppl","key":"49_CR29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.59.6_suppl_4.S3","volume":"59","author":"TR Henry","year":"2002","unstructured":"Henry TR: Therapeutic mechanisms of vagus nerve stimulation. Neurology 2002, 59(6 Suppl 4):S3-S14.","journal-title":"Neurology"},{"key":"49_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0920-1211(95)00035-9","volume":"22","author":"DK Naritoku","year":"1995","unstructured":"Naritoku DK, Terry WJ, Helfert RH: Regional induction of fos immunoreactivity in the brain by anticonvulsant stimulation of the vagus nerve. Epilepsy Res 1995, 22:53\u201362.","journal-title":"Epilepsy Res"},{"key":"49_CR31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0022-3956(03)00074-8","volume":"37","author":"JH Chae","year":"2003","unstructured":"Chae JH, Nahas Z, Lomarev M, et al.: A review of functional neuroimaging studies of vagus nerve stimulation (VNS). J Psychiatr Res 2003, 37:443\u2013455. A comprehensive review of the imaging literature associated with VNS therapy.","journal-title":"J Psychiatr Res"},{"key":"49_CR32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0920-1211(94)00083-9","volume":"20","author":"E Ben-Menachem","year":"1995","unstructured":"Ben-Menachem E, Hamberger A, Hedner T, et al.: Effects of vagus nerve stimulation on amino acids and other metabolites in the CSF of patients with partial seizures. Epilepsy Res 1995, 20:221\u2013227.","journal-title":"Epilepsy Res"},{"key":"49_CR33","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.biopsych.2004.06.025","volume":"56","author":"LL Carpenter","year":"2004","unstructured":"Carpenter LL, Moreno FA, Kling MA, et al.: Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients. Biol Psychiatry 2004, 56:418\u2013426.","journal-title":"Biol Psychiatry"},{"key":"49_CR34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1034\/j.1600-0404.2002.00129.x","volume":"105","author":"L Nagarajan","year":"2002","unstructured":"Nagarajan L, Walsh P, Gregory P, Lee M: VNS therapy in clinical practice in children with refractory epilepsy. Acta Neurol Scand 2002, 105:13\u201317.","journal-title":"Acta Neurol Scand"},{"key":"49_CR35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1528-1157.1998.tb01151.x","volume":"39","author":"SC Schachter","year":"1998","unstructured":"Schachter SC, Saper CB: Vagus nerve stimulation. Epilepsia 1998, 39:677\u2013686.","journal-title":"Epilepsia"},{"issue":"Suppl 16","key":"49_CR36","first-page":"10","volume":"62","author":"HA Sackeim","year":"2001","unstructured":"Sackeim HA: The definition and meaning of treatment-resistant depression. J Clin Psychiatry 2001, 62(Suppl 16):10\u201317.","journal-title":"J Clin Psychiatry"},{"key":"49_CR37","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0006-3223(99)00304-2","volume":"47","author":"AJ Rush","year":"2000","unstructured":"Rush AJ, George MS, Sackeim HA, et al.: Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 2000, 47:276\u2013286.","journal-title":"Biol Psychiatry"},{"key":"49_CR38","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0893-133X(01)00271-8","volume":"25","author":"HA Sackeim","year":"2001","unstructured":"Sackeim HA, Rush AJ, George MS, et al.: Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001, 25:713\u2013728.","journal-title":"Neuropsychopharmacology"},{"key":"49_CR39","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0006-3223(01)01343-9","volume":"51","author":"LB Marangell","year":"2002","unstructured":"Marangell LB, Rush AJ, George MS, et al.: Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes. Biol Psychiatry 2002, 51:280\u2013287.","journal-title":"Biol Psychiatry"},{"key":"49_CR40","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.4088\/JCP.v66n0902","volume":"66","author":"Z Nahas","year":"2005","unstructured":"Nahas Z, Marangell LB, Husain MM, et al.: Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 2005, 66:1097\u20131104. Two-year long-term outcome of adjunctive VNS therapy.","journal-title":"J Clin Psychiatry"},{"key":"49_CR41","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"12","author":"M Hamilton","year":"1960","unstructured":"Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 12:56\u201362.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"49_CR42","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.biopsych.2005.05.025","volume":"58","author":"AJ Rush","year":"2005","unstructured":"Rush AJ, Marangell LB, Sackeim HA, et al.: Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry 2005, 58:347\u2013354.","journal-title":"Biol Psychiatry"},{"key":"49_CR43","first-page":"212S","volume":"53","author":"Z Nahas","year":"2003","unstructured":"Nahas Z, Bohning DE, Mu Q, et al.: Serial vagus nerve stimulation functional MRI (VNS\/fMRI) in treatment-resistant depression. Biol Psychiatry 2003, 53(Suppl):212S.","journal-title":"Biol Psychiatry"},{"key":"49_CR44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.biopsych.2005.05.024","volume":"58","author":"AJ Rush","year":"2005","unstructured":"Rush AJ, Sackeim HA, Marangell LB, et al.: Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry 2005, 58:355\u2013363. VNS therapy over 1-year period and progressive response in TRD.","journal-title":"Biol Psychiatry"},{"key":"49_CR45","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.biopsych.2005.07.028","volume":"58","author":"MS George","year":"2005","unstructured":"George MS, Rush AJ, Marangell LB, et al.: A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 2005, 58:364\u2013373. VNS therapy when compared with current clinical practice for TRD.","journal-title":"Biol Psychiatry"},{"key":"49_CR46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1192\/bjp.bp.105.018689","volume":"189","author":"CD Corcoran","year":"2006","unstructured":"Corcoran CD, Thomas P, Phillips J, O\u2019Keane V: Vagus nerve stimulation in chronic treatment-resistant depression: preliminary findings of an open-label study. Br J Psychiatry 2006, 189:282\u2013283. VNS therapy (European experience) with small sample.","journal-title":"Br J Psychiatry"},{"key":"49_CR47","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00004691-200109000-00007","volume":"18","author":"B Koo","year":"2001","unstructured":"Koo B, Ham SD, Sood S, Tarver B: Human vagus nerve electrophysiology: a guide to vagus nerve stimulation parameters. J Clin Neurophysiol 2001, 18:429\u2013433.","journal-title":"J Clin Neurophysiol"},{"key":"49_CR48","unstructured":"Sackeim HA, Rush AJ, Marangell LB, et al.: Long-term antidepressant effects of vagus nerve stimulation (VNS) in treatment-resistant depression. Poster presented at the 43rd Annual Meeting of the American College of Neuropsychopharmacology. San Juan, Puerto Rico; December 12-16, 2004."},{"key":"49_CR49","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.biopsych.2003.09.015","volume":"55","author":"J Prudic","year":"2004","unstructured":"Prudic J, Olfson M, Marcus SC, et al.: Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry 2004, 55:301\u2013312.","journal-title":"Biol Psychiatry"},{"key":"49_CR50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.yct.0000230364.04240.52","volume":"22","author":"MJ Burke","year":"2006","unstructured":"Burke MJ, Husain MM: Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatmentresistant depression. J Ect 2006, 22:218\u2013222.","journal-title":"J Ect"},{"key":"49_CR51","doi-asserted-by":"crossref","unstructured":"Lurie P, Stine N: Responding to three articles regarding vagus nerve stimulation (VNS) for depression. Biol Psychiatry 2006. [Epub ahead of print].","DOI":"10.1016\/j.biopsych.2006.05.032"},{"key":"49_CR52","doi-asserted-by":"crossref","unstructured":"Rush AJ, George MS: Reply. Biol Psychiatry 2006. [Epub ahead of print].","DOI":"10.1016\/j.biopsych.2006.05.021"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-006-0049-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-006-0049-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-006-0049-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:41:08Z","timestamp":1559421668000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-006-0049-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1007\/s11920-006-0049-4","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}